MARATTO

article · BMC Pediatrics

Diagnostic and management challenges of a case of N-acetylglutamate synthase deficiency in a resource-limited healthcare setting in Tanzania: a case report

In plain language

Inborn errors of metabolism contribute significantly to illness and death in children, yet they are often overlooked in low-resource environments because they are rare and mimic common conditions like sepsis. A case report from Tanzania details a three-day-old infant who presented with lethargy, low body temperature, and respiratory distress, initially treated for suspected septic shock. Subsequent testing identified severe hyperammonemia, prompting treatment with peritoneal dialysis and oral sodium benzoate. Care involved a multidisciplinary team supported by teleconsultation with an international metabolic specialist. After initial stabilisation, the infant was transferred to a partner hospital in Pakistan, where genetic testing identified a homozygous pathogenic mutation in the N-acetylglutamate synthase gene. Although the infant died on day 49, the experience demonstrates that cross-border partnerships and high clinical suspicion can improve the management of rare metabolic disorders in resource-limited facilities.

Key takeaways

  • Inborn errors of metabolism are frequently misdiagnosed as conditions such as sepsis in low-resource settings.
  • A neonate with severe hyperammonemia was temporarily stabilised using peritoneal dialysis and oral sodium benzoate alongside remote specialist consultation.
  • Genetic testing in an international partner institution confirmed a homozygous pathogenic variant causing N-acetylglutamate synthase deficiency.
  • International collaboration and multidisciplinary care can support the management of rare metabolic conditions in low-resource environments.

Why it matters

Rare genetic conditions can be fatal if mistaken for common neonatal infections. This report highlights how healthcare facilities in resource-limited settings can leverage teleconsultation, local interventions, and international partnerships to identify and treat complex metabolic diseases, emphasising the need for improved local diagnostic tools and standard treatment protocols.

Commercialisation angle

The abstract does not indicate an application pathway, as it is a clinical case report focused on medical management and diagnostic challenges.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

BACKGROUND: Inborn errors of metabolism represent a significant cause of childhood morbidity and mortality. These conditions are frequently missed in low-resource settings due to their anticipated rarity and similarity of symptoms to conditions such as sepsis. We present a case of a neonate with N-acetylglutamate synthase deficiency whose diagnosis and management at our facility were complicated by limited healthcare resources. CASE REPORT: A three-day-old male of South Asian origin born to consanguineous parents presented with lethargy, hypothermia and respiratory distress. He was initially managed for suspected septic shock. However, further investigations revealed severe hyperammonemia for which he was managed with peritoneal dialysis and oral sodium benzoate. His care was coordinated by a multidisciplinary team and included teleconsultation with a metabolic specialist. Once stabilized, he was transferred to our sister institution in Pakistan for further care where genetic analysis revealed a homozygous pathogenic variant (c.1306_1307insT; p.Thr439fs*52) in the N-acetylglutamate synthase gene, confirming the diagnosis of N-acetylglutamate synthase deficiency. However, the baby passed away at 49th day of life. CONCLUSION: High index of suspicion is important in diagnosing inborn errors of metabolism. Even in resource-limited setting, a multidisciplinary team with international partnership can optimize the care for patients with rare inborn errors of metabolism. There is also a need to increase awareness, improve diagnostic capacity and establish standardized treatment protocols for rare metabolic disorders in low-resource settings like Tanzania.

Research topics

  • Metabolism and Genetic Disorders
  • Genomics and Rare Diseases
  • Biochemical and Molecular Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1186/s12887-025-06449-z

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.